Holland & Knight Represents EmVenio Research in Acquisition by PCM Trials
March 05, 2024
March 05, 2024
CHATTANOOGA, Tennessee, March 5 -- Holland and Knight, a law firm, issued the following news release:
Holland & Knight advised EmVenio Research, the largest provider of community-based clinical trial sites served with mobile research units, in its acquisition by PCM Trials. The acquisition, which is effective immediately, was announced on February 23.
With the combination of capabilities with EmVenio, PCM Trials now has access to a site network that is focused on se . . .
Holland & Knight advised EmVenio Research, the largest provider of community-based clinical trial sites served with mobile research units, in its acquisition by PCM Trials. The acquisition, which is effective immediately, was announced on February 23.
With the combination of capabilities with EmVenio, PCM Trials now has access to a site network that is focused on se . . .